Journal of Cachexia, Sarcopenia and Muscle (Dec 2021)

Glycine increases fat‐free mass in malnourished haemodialysis patients: a randomized double‐blind crossover trial

  • Laurence Genton,
  • Daniel Teta,
  • Menno Pruijm,
  • Catherine Stoermann,
  • Nicola Marangon,
  • Julie Mareschal,
  • Isabelle Bassi,
  • Arelene Wurzner‐Ghajarzadeh,
  • Vladimir Lazarevic,
  • Luc Cynober,
  • Patrice D. Cani,
  • François R. Herrmann,
  • Jacques Schrenzel

DOI
https://doi.org/10.1002/jcsm.12780
Journal volume & issue
Vol. 12, no. 6
pp. 1540 – 1552

Abstract

Read online

Abstract Background Protein energy wasting is associated with negative outcome in patients under chronic haemodialysis (HD). Branched‐chain amino acids (BCAAs) may increase the muscle mass. This post hoc analysis of a controlled double‐blind randomized crossover study assessed the impact of BCAAs on nutritional status, physical function, and quality of life. Methods We included 36 chronic HD patient features of protein energy wasting as plasma albumin 80% of packs) and completed the study. BCAA did not affect lean body mass index and body weight, but significantly decreased fat‐free mass index, as compared with glycine (coeff −0.27, 95% confidence interval −0.43 to −0.10, P = 0.002, respectively). BCAA and glycine intake had no effect on the other clinical parameters, blood chemistry tests, or plasma amino acids. Conclusions Branched‐chain amino acid did not improve lean body mass as compared with glycine. Unexpectedly, glycine improved fat‐free mass index in HD patients, as compared with BCAA. Whether long‐term supplementation with glycine improves the clinical outcome remains to be demonstrated.

Keywords